三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
奥雷巴替尼治疗CML-CP美国数据
奥雷巴替尼治疗CML-CP美国数据
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:466KB
图片尺寸:1263*743
同报告图片
/
4
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
fCDkuqflk4EgIHwg5LyB5LiaICAgfCDlm73lhoXkuLTluorpmLbmrrUgfAp8LS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDlpaXpm7flt7Tmm7/lsLwgfCDkuprnm5vljLvoja8gfCDkuIrluIIgICAgICAgICAgfAp8IOaZrue6s+abv+WwvCAgIHwg5q2m55SwICAgICB8IElJSSAgICAgICAgICAgfAp8IFRHUlgtNjc4IHwg5aGU5ZCJ55Ge55Sf54mpIHwgSSAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOilv+WNl+ivgeWIuOaVtOeQhg==
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
所属报告:
亚盛医药-港股公司研究报告-小荷才露尖尖角细胞凋亡赛道大有可为-230507(36页).pdf
打包全文图表
相关数据
慢性髓系白血病(CML)临床诊疗流程
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
收藏
行业数据
2025-08-25
原图定位
查看详情
图8奥雷巴替尼临床获益以及耐受性情况
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
收藏
行业数据
2025-06-30
原图定位
查看详情
图9奥雷巴替尼临床获益以及耐受性情况(续)
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
收藏
行业数据
2025-06-30
原图定位
查看详情
图11奥雷巴替尼在Ph+ALL适应症的临床疗效(续)
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
收藏
行业数据
2025-06-30
原图定位
查看详情
图7奥雷巴替尼(HQP1351)临床推进情况
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
收藏
行业数据
2025-06-30
原图定位
查看详情
用于CML治疗的TKIs获批上市和医保目录纳入情况
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
收藏
行业数据
2025-06-09
原图定位
查看详情
CML致病机制与奥雷巴替尼(HQP1351)作用通路示意
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
收藏
行业数据
2025-02-06
原图定位
查看详情
奥雷巴替尼(HQP1351)临床发展计划
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
收藏
行业数据
2025-02-06
原图定位
查看详情
慢性髓性白血病(CML)慢性期(CP)患者治疗方案
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
收藏
行业数据
2024-12-30
原图定位
查看详情
第三代BCR-ABL抑制剂奥雷巴替尼已获批上市,Bcl-2抑制剂针对慢淋国内已申报NDA
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
收藏
行业数据
2024-12-26
原图定位
查看详情
针对BCR-ABL融合蛋白的TKI类药物目前是治疗CML的首选
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
收藏
行业数据
2024-12-26
原图定位
查看详情
预计全球与中国CML新发患者逐年缓慢增长(千人)
fCDlubTku70gfCDkuK3lm73vvIjljYPkurrvvIkgfCDnvo7lm73vvIjljYPkurrvvIkgfCDlhbbku5bvvIjljYPkurrvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IDIwMTkgfCAyMCAgICAgICAgICAgfCAxMCAgICAgICAgICAgfCAzMCAgICAgICAgICAgfAp8IDIwMjAgfCAyMiAgICAgICAgICAgfCAxMiAgICAgICAgICAgfCAzNCAgICAgICAgICAgfAp8IDIwMjEgfCAyNCAgICAgICAgICAgfCAxNCAgICAgICAgICAgfCAzNiAgICAgICAgICAgfAp8IDIwMjIgfCAyNiAgICAgICAgICAgfCAxNiAgICAgICAgICAgfCAzOCAgICAgICAgICAgfAp8IDIwMjMgfCAyOCAgICAgICAgICAgfCAxOCAgICAgICAgICAgfCA0MCAgICAgICAgICAgfAp8IDIwMjRFfCAzMCAgICAgICAgICAgfCAyMCAgICAgICAgICAgfCA0MiAgICAgICAgICAgfAp8IDIwMjVFfCAzMiAgICAgICAgICAgfCAyMiAgICAgICAgICAgfCA0NCAgICAgICAgICAgfAp8IDIwMjZFfCAzNCAgICAgICAgICAgfCAyNCAgICAgICAgICAgfCA0NiAgICAgICAgICAgfAp8IDIwMjdFfCAzNiAgICAgICAgICAgfCAyNiAgICAgICAgICAgfCA0OCAgICAgICAgICAgfAp8IDIwMjhFfCAzOCAgICAgICAgICAgfCAyOCAgICAgICAgICAgfCA1MCAgICAgICAgICAgfAp8IDIwMjlFfCA0MCAgICAgICAgICAgfCAzMCAgICAgICAgICAgfCA1MiAgICAgICAgICAgfAp8IDIwMzBFfCA0MiAgICAgICAgICAgfCAzMiAgICAgICAgICAgfCA1NCAgICAgICAgICAgfAp8IDIwMzFFfCA0NCAgICAgICAgICAgfCAzNCAgICAgICAgICAgfCA1NiAgICAgICAgICAgfAp8IDIwMzJFfCA0NiAgICAgICAgICAgfCAzNiAgICAgICAgICAgfCA1OCAgICAgICAgICAgfAp8IDIwMzNFfCA0OCAgICAgICAgICAgfCAzOCAgICAgICAgICAgfCA2MCAgICAgICAgICAgfAp8IDIwMzRFfCA1MCAgICAgICAgICAgfCA0MCAgICAgICAgICAgfCA2MiAgICAgICAgICAgfAp8IDIwMzVFfCA1MiAgICAgICAgICAgfCA0MiAgICAgICAgICAgfCA2NCAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaRnJvc3QgJiBTdWxsaXZhbuOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2024-12-26
原图定位
查看详情
奥雷巴替尼(HQP1351)作用机制
fCBCQ1ItQUJMIHd0IHwgU1RBVDUgfCBSQVMtR1RQIHwgQ1JLTCB8IENSSyB8IFBJM0sgfAp8LS0tLS0tLS0tLS0tLXwtLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tfC0tLS0tfC0tLS0tLXwKfCDmipfnmYzmgKcgICAgICAgfCAgICAgICB8ICAgICAgICAgfCAgICAgICB8ICAgICB8ICAgICAgfAp8IOaPkOWNh+e7huiDnuWinuauluWSjOWtmOa0u++8iOeZjOeXh++8iSB8ICAgICAgIHwgICAgICAgICB8ICAgICAgIHwgICAgIHwgICAgICB8Cnwg57uG6IOe5q275LqhICAgICB8ICAgICAgIHwgICAgICAgICB8ICAgICAgIHwgICAgIHwgICAgICB8CgrotYTmlpnmnaXmupDvvJrkuprnm5vljLvoja/mi5vogqHkuabvvIzplb/msZ/or4HliLjnoJTnqbbmiYA=
收藏
行业数据
2024-08-08
原图定位
查看详情
治疗BCR-ABLT315I突变CML疗及安全对比
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
收藏
行业数据
2024-08-08
原图定位
查看详情
图23、奥雷巴替尼国内样本医院季度销售额及增速情况
5qC55o2u5Zu+54mH5Lit55qE5p+x54q25Zu+77yM5Y+v5Lul5o+Q5Y+W5Lul5LiL5pWw5o2u77yaCgp8IOWto+W6piAgICB8IOmHkemine+8iOeZvuS4h+WFg++8iSB8CnwtLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIyUTIgIHwgMC4xICAgICAgICAgICAgfAp8IDIwMjJRMyAgfCAwLjMgICAgICAgICAgICB8CnwgMjAyMlE0ICB8IDAuMiAgICAgICAgICAgIHwKfCAyMDIzUTEgIHwgMS4wICAgICAgICAgICAgfAp8IDIwMjNRMiAgfCA1LjUgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpQREIsIOS/oei+vuivgeWIuOeglOWPkeS4reW/gw==
收藏
行业数据
2023-12-06
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
在 2022ASH 上,亚盛医药公布了耐立克在难治性 CML 和 Ph+ALL 海外患者中的疗效和安全性数据。研究入组 51例患者,包括 38例 CML-CP患者,13例 CML-AP、CML-BP和 Ph+ALL患者,其中 54.9%的患者曾接受过第三代 TKI 普纳替尼的治疗。疗效方面,在 23 例可评估的 CML-CP 患者中,77.8%获得 CcyR,43.5%获得 MMR。奥雷巴替尼对 T315I突变的患者(87.5%,CCyR;55.6%, MMR)和不伴有 T315I突变的患者(70.0%,CCyR;35.7%,MMR)都有效,其有效性并未因先前使用过 ponatinib 或 asciminib 而受到影响。
行业数据
原图定位
当前图表所属:
亚盛医药-港股公司研究报告-小荷才露尖尖角细胞凋亡赛道大有可为-230507(36页).pdf
奥雷巴替尼销售额预测(亿元)
三代BCRABLTKI疗效及安全性对比
国内三代BCRABLTKI在研格局
我国BCRABLTKI竞争格局
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》